Proton and Photon Consortium Registry Tracking Pediatric Patients Receiving Radiation Therapy Across Multiple Centers
Led by Massachusetts General Hospital · Updated on 2026-10-05
5000
Participants Needed
26
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are gathering information on children treated with radiation therapy for cancer to better understand the benefits and risks of different radiation methods, particularly proton beam radiation therapy PBRT. PBRT has shown promise in targeting tumors more precisely and causing fewer long-term side effects, but more data is needed to confirm these advantages. This registry study aims to collect detailed demographic and clinical data from multiple centers to support future research and collaboration.
Participants will receive their cancer treatment as determined by their doctors, including any surgeries, chemotherapy, and radiation therapy. The study will record all treatments and monitor outcomes such as treatment response, side effects, and cancer progression. Data collected at screening includes patient demographics, diagnosis details, imaging, lab tests, and treatment history. Treatment data will track radiation doses, timing, and concurrent therapies.
After treatment, participants will be followed annually to update their health status, including disease progression, hospitalizations, new medical conditions, medications, and long-term side effects like hearing or hormonal issues. Researchers will collect medical records and test results over time to understand short- and long-term effects of radiation therapy. This lifelong follow-up helps evaluate the outcomes of proton beam radiation therapy in children with cancer.
CONDITIONS
Brief Title
Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy
Research Team
T
Torunn I Yock, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients treated with radiation therapy at one of the participating centers
Less than 22 years old at the start of radiation treatment
Patients can have received any prior local or systemic treatments before enrollment
Patients may have any disease extent or be receiving other treatments during the study
Patients can participate even if enrolled in other clinical trials
You will not qualify if you...
None specified
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment and Data Collection
Duration - Varies by participant
Participants receive their cancer treatment as determined by their doctors. The study collects information on all treatments, including surgery, chemotherapy, and radiation therapy, as well as any side effects and treatment responses.
Data collected during routine care visits
Follow-up
Duration - Ongoing annual follow-up
Participants are followed annually through medical record reviews and updates on health status, including new medical issues, hospitalizations, and long-term side effects. The study aims to track participants' health for their lifetime.
Annual data updates and health status reviews
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR).
Jacquelyn M Krisch, Ralph P Ermoian, Daniel J Indelicato...